All News
Anti-Vaxxer Gets 5 Years for Encouraging Terrorism During the Pandemic
(MedPage Today) -- LONDON -- An opponent of vaccines who wrote social media posts urging violence against scientists, politicians, and public health officials during the COVID-19 pandemic was sente
Read MoreRise in NICs will endanger public health services | Letter
While the NHS has been given an exemption to the NIC increase, health services commissioned outside the health service have not, says Greg FellYour article outlining the extra strain on council budget
Read MoreThe State of Infectious Disease Control in Africa
(MedPage Today) -- In part 3 of this exclusive video interview, MedPage Today's editor-in-chief Jeremy Faust, MD, talks with Craig Spencer, MD, MPH, of Brown University in Providence, Rhode Island, a
Read MoreAt Long Last, the Surge in S.T.I.s May Be Leveling Off
Rates of gonorrhea declined in 2023, while diagnoses of syphilis and chlamydia held roughly steady, according to new C.D.C. data.
Read MoreVeterans With PTSD Making Progress Thanks to Service Dog Program
(MedPage Today) -- KANSAS CITY, Kan. -- After working at a crowded and dangerous internment camp in Iraq, Air Force Staff Sgt.
Read MoreRobert F. Kennedy Jr.’s FDA Wish List: Raw Milk, Stem Cells, Heavy Metals
Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight on many fronts.
Read MoreLifestyle and Parkinson's Risk; Air Cleaners and Illness; Stockpiling Birth Control
(MedPage Today) -- Note that some links may require registration or subscription. Aerobic exercise has been linked with Parkinson's disease progression and risk.
Read MoreOficiales de salud en California responden rápido a los casos de dengue
En lo que va del año, las autoridades han identificado al menos 13 casos de dengue de transmisión local, frente a dos en 2023, con 11 en el condado de Los Ángeles y dos en el área de San Diego.
Read MoreSTAT+: Pharmalittle: We’re reading about 23andMe retrenching, AstraZeneca reworking cancer drug plans, and more
23andMe announced it would halt efforts to develop new medicines and lay off 40% of its workforce
Read MoreYear in Review: Early Breast Cancer
(MedPage Today) -- News in early breast cancer this year was marked by updated U.S.
Read More